PROVIDUS
LIVE

Serial Number

99310861

Owner

ITALFARMACO S.P.A.

Attorney

Courtney Thompson

First Use Date

Jun 20, 2025

Filing Date

Jul 30, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PROVIDUS Trademark

Serial Number: 99310861

PROVIDUS is a trademark filed by ITALFARMACO S.P.A. on July 30, 2025. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

ITALFARMACO S.P.A.

Viale Fulvio Testi, 330
Milan (MI) 20126 , IT

Entity Type: 35

Trademark Details

Filing Date

July 30, 2025

Registration Date

Not Registered

First Use Anywhere

June 20, 2025

First Use in Commerce

June 20, 2025

Goods & Services

Scientific and technological services, namely, scientific research, pharmaceutical drug development, and biochemical analysis in the field of drug discovery; medical research and conducting clinical trials for pharmaceutical products; data computer modeling services in the field of pharmaceutical development and medical technology; Scientific services and research namely conducting scientific pharmaceutical product feasibility studies and product designing medical devices and instruments for clinical trials; Scientific services and product design, namely conducting scientific pharmaceutical product feasibility studies and designing medical devices and instruments for clinical trials; Platform as a service (PAAS) comprising software platforms for the transmission of images, audiovisual content, video content and messages; Scientific research for medical purposes; product research services, design and development of instruments for control and diagnostics; Scientific research; Electronic data storage; Technical writing, namely medical writing services for the development of medical protocols, clinical study reports, researcher pamphlets, safety reports, informed consent forms, meeting summaries, posters, manuscripts, study diagrams, manuals, and literature reviews; Design, implementation and management of clinical and observational clinical research study protocols; Electronic storage of files and documents; computer diagnostic services; computer systems analysis services; providing online non-downloadable software featuring clinical study and clinical trial management system tools via a website; providing online non-downloadable software featuring access to study management files; programming of software for study management files and electronic storage services for archiving temporary files throughout the clinical study lifecycle; scientific research, namely programming of software for biostatistics, development of protocols for sample size and statistical power calculations, randomization plans, statistical analysis plans; programming of computer software for validation in a statistical analysis system for others; providing online non-downloadable software enabling interpretation and reporting of data for clinical trial reports and publications; product development for others; scientific research, namely intermediate analysis for early decision making in clinical trials; providing online non-downloadable software for providing access to databases and data lists ready for a New Drug Application (NDA), regulatory submission-compliant data files, study data tabulation and data on model regulatory submission standards; medical research and development for new products for others in the field of medical surveillance and safety plans ongoing oversight of patient-level studies and review of safety data, interpretation of study protocol, consultation on potential safety and medical issues and 24/7 medical surveillance coverage; pharmaceutical drug development services; drug discovery services of adverse events from clinical trials; pharmaceutical drug development services, namely, development of safety update reports and other aggregate reports, development of management safety plans and medical surveillance plans; product quality testing of clinical trial's documentation, for example, standard operating procedures (sops) and work instructions, internal system reviews, site audits, provider evaluations; Medical research in the field of pharmacology namely simulation, dose selection and optimization, biomarker and endpoint selection, study design optimization, population pharmacokinetic and pharmacodynamic modeling, exposure response modeling; Medical research; Information related to scientific and medical research in the area of clinical trials, namely the design of clinical trials and outcome measures for studying human diseases, or studying or testing drugs, devices, or medical treatment methods on humans; scientific research in the nature of conducting clinical trials for third parties studying human diseases, or studying or testing drugs, devices, or medical treatment methods on humans; Custom computer programming in the field of image training and integration into computer systems of suitability data with interactive response technology (IRT); product design and development of computer databases for the collection, storage, management, analysis and validation of data for use in the medical and pharmaceutical fields; electronic data storage services for archiving presentations; Providing information on clinical studies via an interactive website.

Healthcare services, namely, monitoring and follow-up of patients enrolled in non-interventional studies; Providing medical information in the context of real-world evidence (RWE) and post-market studies.

Filing History

NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 24, 2026 GNFN
FINAL REFUSAL E-MAILED
Mar 24, 2026 GNFR
FINAL REFUSAL WRITTEN
Mar 24, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 3, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 3, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 3, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 19, 2025 GNRN
NON-FINAL ACTION E-MAILED
Dec 19, 2025 GNRT
NON-FINAL ACTION WRITTEN
Dec 19, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 15, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 8, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 8, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 30, 2025 MAFR
NEW APPLICATION ENTERED
Jul 30, 2025 NWAP